Jordan P Safran, Bita Momenaei, Jonathan Martin, Benjamin Crain, Collin Richards, Richard Kaiser, Sunir J Garg, Arunan Sivalingam, Marc Spirn, Jason Hsu
{"title":"Rhegmatogenous Retinal Detachment Following Vitrectomy and Subretinal Tissue Plasminogen Activator for Submacular Hemorrhage.","authors":"Jordan P Safran, Bita Momenaei, Jonathan Martin, Benjamin Crain, Collin Richards, Richard Kaiser, Sunir J Garg, Arunan Sivalingam, Marc Spirn, Jason Hsu","doi":"10.1097/IAE.0000000000004417","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the incidence and outcomes of rhegmatogenous retinal detachment (RRD) occurring after pars plana vitrectomy (PPV) and subretinal tissue plasminogen activator (tPA) for submacular hemorrhage (SMH).</p><p><strong>Methods: </strong>Charts were reviewed between April 1, 2014 and September 1, 2023 for eyes that underwent PPV/subretinal tPA for SMH.</p><p><strong>Results: </strong>Out of 167 eyes, 15 (9%) eyes developed RRD with macular detachment in 12 (80%) and proliferative vitreoretinopathy (PVR) in 9 eyes (60%). The median (interquartile range, IQR) time from PPV/subretinal tPA until RRD diagnosis was 41 (22-81) days. Single-surgery anatomic success was achieved in 11 eyes (85%) at three months and 9 eyes (70%) at the final visit. Four eyes (27%) developed redetachment and three underwent a median of two additional repairs. The final anatomic success rate for reattachment was 92% (12/13). The median (IQR) logMAR [Snellen] visual acuity at the preoperative visit following SMH was 2 (2-2.3) [20/2000], which worsened to 2.3 (2.2-2.7) [20/4000] at the time of RRD diagnosis (P=0.01) and plateaued by the final visit to 2.3 (2-2.7) [20/4000] (P=0.15).</p><p><strong>Conclusion: </strong>Postoperative RRD occurred in nearly 1 in 10 eyes after PPV/subretinal tPA for SMH and was associated with a relatively high rate of PVR.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina-The Journal of Retinal and Vitreous Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IAE.0000000000004417","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To investigate the incidence and outcomes of rhegmatogenous retinal detachment (RRD) occurring after pars plana vitrectomy (PPV) and subretinal tissue plasminogen activator (tPA) for submacular hemorrhage (SMH).
Methods: Charts were reviewed between April 1, 2014 and September 1, 2023 for eyes that underwent PPV/subretinal tPA for SMH.
Results: Out of 167 eyes, 15 (9%) eyes developed RRD with macular detachment in 12 (80%) and proliferative vitreoretinopathy (PVR) in 9 eyes (60%). The median (interquartile range, IQR) time from PPV/subretinal tPA until RRD diagnosis was 41 (22-81) days. Single-surgery anatomic success was achieved in 11 eyes (85%) at three months and 9 eyes (70%) at the final visit. Four eyes (27%) developed redetachment and three underwent a median of two additional repairs. The final anatomic success rate for reattachment was 92% (12/13). The median (IQR) logMAR [Snellen] visual acuity at the preoperative visit following SMH was 2 (2-2.3) [20/2000], which worsened to 2.3 (2.2-2.7) [20/4000] at the time of RRD diagnosis (P=0.01) and plateaued by the final visit to 2.3 (2-2.7) [20/4000] (P=0.15).
Conclusion: Postoperative RRD occurred in nearly 1 in 10 eyes after PPV/subretinal tPA for SMH and was associated with a relatively high rate of PVR.
期刊介绍:
RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice.
In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color.
Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.